Biotest Pharma Gmbh
SpainAll drugs from this manufacturer
-
It is used to restore and maintain circulating blood volume when there is low blood volume and the use of a colloid such as albumin is necessary.
Dosage form: solution for infusion
Active substance Dosage human plasma protein 200 g albumin AL MENOS 96 % -
It is used to treat and prevent bleeding in people with hemophilia A (a congenital deficiency of factor VIII).
Dosage form: powder and solvent for solution for injection
Active substance Dosage human factor viii 100 UI -
It is used to treat and prevent bleeding in people with hemophilia A (a congenital factor VIII deficiency).
Dosage form: powder and solvent for solution for injection
Active substance Dosage human factor viii 50 UI -
It is used to provide immediate and prolonged protection against hepatitis B. It serves to prevent infection in unvaccinated individuals or those with insufficient protection, in newborns of infected mothers, in liver transplant patients who test positive for hepatitis B, and to protect those who have been accidentally exposed to the virus.
Dosage form: solution for infusion
Active substance Dosage human antihepatitis b immunoglobulin 50 mg -
It is used to treat people (adults, children, and adolescents) who do not have enough antibodies to defend themselves against diseases, whether due to a congenital deficiency or an acquired one. It is also used to treat various inflammatory diseases such as Guillain-Barré syndrome, Kawasaki disease, or primary immune thrombocytopenia.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat people who do not have enough antibodies (either from birth or because they have acquired a deficiency due to serious infections) and to treat various inflammatory diseases such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain nerve diseases.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used to help prevent the onset of cytomegalovirus infections in patients receiving immunosuppressive treatments, especially after an organ transplant.
Dosage form: solution for infusion
Active substance Dosage cytomegalovirus immunoglobulin 100 U/ml